toplogo
Zaloguj się
spostrzeżenie - Computer Vision - # Polyp Segmentation in Colonoscopy

Autonomous Polyp Segmentation in Colonoscopy using a Hybrid YOLO-SAM 2 Model


Główne pojęcia
A novel self-prompting polyp segmentation model that integrates the YOLOv8 object detection and SAM 2 segmentation models to achieve high accuracy and efficiency with reduced annotation effort.
Streszczenie

The paper presents a novel approach to polyp segmentation in colonoscopy images and videos by integrating the YOLOv8 object detection model and the Segment Anything Model (SAM 2). The key highlights are:

  1. The proposed method leverages YOLOv8's bounding box predictions to autonomously generate input prompts for the SAM 2 model, reducing the need for manual annotations.
  2. Extensive experiments on five benchmark colonoscopy image datasets and two video datasets demonstrate that the YOLO-SAM 2 model outperforms state-of-the-art methods in both image and video segmentation tasks.
  3. The approach achieves high segmentation accuracy using only bounding box annotations, significantly reducing the annotation time and effort compared to previous methods that required detailed ground truth segmentation masks.
  4. The lightweight nature of the combined YOLO-SAM 2 model enables real-time video segmentation, making it suitable for clinical applications.
edit_icon

Dostosuj podsumowanie

edit_icon

Przepisz z AI

edit_icon

Generuj cytaty

translate_icon

Przetłumacz źródło

visual_icon

Generuj mapę myśli

visit_icon

Odwiedź źródło

Statystyki
The proposed YOLO-SAM 2 model achieves a mean Intersection over Union (mIoU) of 0.909 and a mean Dice coefficient of 0.951 on the CVC-ClinicDB dataset, outperforming previous state-of-the-art methods by 9.8% and 11%, respectively. On the ETIS-LaribPolypD dataset, YOLO-SAM 2 improves the mIoU and mean Dice coefficient by 14.8% and 18% compared to the previous best methods. For video segmentation on the SUN-SEG dataset, YOLO-SAM 2 outperforms the previous best method by achieving a 7.5% higher Dice score for the SUN-SEG-Unseen-Easy subset and an 8% higher Dice score for the SUN-SEG-Unseen-Hard subset. On the PolypGen dataset, YOLO-SAM 2 achieves a remarkable 20.7% increase in mean Intersection over Union (mIoU) compared to previous state-of-the-art methods.
Cytaty
"Our approach focuses on utilizing only bounding box data to train the overall segmentation model, leveraging the zero-shot capabilities of SAM 2 to minimize the need for extensive data annotation." "Notably, our approach achieves high segmentation accuracy using only bounding box annotations, significantly reducing annotation time and effort."

Głębsze pytania

How can the YOLO-SAM 2 model be further optimized for real-time clinical deployment, and what are the potential challenges in integrating it into existing medical imaging workflows?

The YOLO-SAM 2 model can be further optimized for real-time clinical deployment through several strategies. First, enhancing the model's inference speed is crucial. This can be achieved by employing model pruning techniques, which reduce the number of parameters without significantly impacting performance, thereby allowing for faster processing times. Additionally, quantization can be utilized to convert the model weights from floating-point to lower precision formats, which can further accelerate inference on compatible hardware. Another optimization avenue is the integration of hardware acceleration, such as utilizing Graphics Processing Units (GPUs) or specialized hardware like Tensor Processing Units (TPUs) that are designed for deep learning tasks. This would enable the model to handle high-resolution images and video streams in real-time, which is essential in clinical settings. However, integrating YOLO-SAM 2 into existing medical imaging workflows presents several challenges. One significant challenge is the need for interoperability with current systems, such as Electronic Health Records (EHR) and Picture Archiving and Communication Systems (PACS). Ensuring that the model can seamlessly communicate with these systems is vital for efficient data exchange and workflow integration. Additionally, there may be resistance from medical professionals who are accustomed to traditional methods, necessitating comprehensive training and education on the new system's benefits and functionalities. Moreover, regulatory compliance is another critical challenge. The model must meet stringent medical device regulations and standards, which can vary by region. This includes ensuring the model's accuracy, reliability, and safety in clinical environments, which may require extensive validation studies and documentation.

What other medical imaging tasks, beyond polyp segmentation, could benefit from the self-prompting capabilities of the YOLO-SAM 2 model, and how would the approach need to be adapted for those applications?

Beyond polyp segmentation, the self-prompting capabilities of the YOLO-SAM 2 model could be beneficial in various medical imaging tasks, including tumor detection in radiology, organ segmentation in MRI scans, and lesion identification in dermatology images. For tumor detection, the model could be adapted by training it to recognize bounding boxes around tumors in CT or MRI scans, using similar self-prompting techniques to generate segmentation masks. The integration of domain-specific knowledge, such as tumor characteristics and typical locations, could enhance the model's performance in this context. In organ segmentation, the approach would need to be tailored to account for the anatomical variations across different patients. The model could be trained on diverse datasets that include various organ shapes and sizes, allowing it to generate accurate segmentations based on bounding box prompts that indicate the organ's location. For dermatology applications, the model could be adapted to identify skin lesions by utilizing high-resolution images and training it to recognize different types of lesions. The self-prompting mechanism could help in generating precise segmentation masks based on bounding boxes that outline the lesions, thus facilitating quicker and more accurate diagnoses.

Given the advancements in foundational models like SAM 2, how might the role of human experts evolve in the annotation and curation of medical imaging datasets, and what are the implications for the future of computer-aided diagnosis systems?

The advancements in foundational models like SAM 2 are likely to significantly transform the role of human experts in the annotation and curation of medical imaging datasets. As self-prompting models reduce the reliance on detailed manual annotations, the role of experts may shift from direct annotation to more of a supervisory and quality control function. Experts will be needed to validate the outputs generated by models, ensuring that the segmentations and detections align with clinical standards and accuracy requirements. Furthermore, human experts may focus on curating high-quality datasets that are diverse and representative of various conditions, which is essential for training robust models. Their expertise will be crucial in identifying gaps in existing datasets and guiding the development of new datasets that address these gaps, particularly in underrepresented conditions or populations. The implications for the future of computer-aided diagnosis systems are profound. With reduced annotation burdens, the speed at which new models can be developed and deployed will increase, potentially leading to faster advancements in diagnostic capabilities. Additionally, as models become more autonomous, there may be a greater emphasis on interpretability and explainability, requiring experts to ensure that the decision-making processes of these models are transparent and understandable to clinicians. Overall, the evolution of human roles in this context will likely lead to a more collaborative approach, where human expertise and machine learning capabilities complement each other, ultimately enhancing the accuracy and efficiency of computer-aided diagnosis systems in clinical practice.
0
star